Annual EBITDA
-$241.49M$64.63M-36.54%
Summary
- Current Value
- As of today, NAMS annual EBITDA is -$241.49M, down -36.54% on
- Historical Performance
- NAMS annual EBITDA is down -483.74% over the past 3 years, and down -3533.17% over the past 5 years
- All-Time High Comparison
- NAMS annual EBITDA is currently -3533.17% below its historical high of -$6.65M set on
- 3-Year Low Comparison
- NAMS annual EBITDA is at its 3-year low
- Sector Comparison
- NAMS annual EBITDA is higher than 6.02% of companies in Healthcare sector
EBITDA Chart
Add series to chart1/6
Series
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual EBITDA | -$241.49M | -36.5% | -483.7% | -3533.2% | -3533.2% | |
| Quarterly EBITDA | -$55.08M | -126.3% | -2301.4% | -10000.0% | -10000.0% | |
| TTM EBITDA | -$202.72M | -54.2% | -3887.7% | -10000.0% | -10000.0% | |
| Price | $35.80 | +40.1% | +202.3% | – | – | |
| PE Ratio | - | – | – | – | – | |
| Annual Revenue | $45.56M | +223.4% | +100.0% | +100.0% | +100.0% | |
| Annual EPS | -$2.56 | -18.9% | -1187.7% | -10000.0% | -10000.0% | |
| Annual EBIT | -$241.60M | -36.6% | -483.9% | -3534.2% | -3534.2% | |
| Annual Net Income | -$241.60M | -36.5% | -5881.9% | -10000.0% | -10000.0% |
EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | -$22.34M | N/A | -981.0% |
| 5Y | -$6.65M | N/A | -3533.2% |
| All | -$6.65M | -3533.2% |
EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | -$241.49M | at low | |
| 5Y | -$241.49M | at low | |
| All | -$241.49M | at low |
EBITDA History
| Year | Value | Change |
|---|---|---|
| -$241.49M | -36.5% | |
| -$176.86M | -691.7% | |
| -$22.34M | +46.0% |
| Year | Value | Change |
|---|---|---|
| -$41.37M | -522.4% | |
| -$6.65M | - |
FAQ
What is the current annual EBITDA of NAMS?
As of today, NAMS annual EBITDA is -$241.49M
What is 1-year change in NAMS annual EBITDA?
NAMS annual EBITDA is down -36.54% year-over-year
What is 3-year change in NAMS annual EBITDA?
NAMS annual EBITDA is down -483.74% over the past 3 years
How far is NAMS annual EBITDA from its all-time high?
NAMS annual EBITDA is currently -3533.17% below its historical high of -$6.65M set on December 1, 2020
How does NAMS annual EBITDA rank versus sector peers?
NAMS annual EBITDA is higher than 6.02% of companies in Healthcare sector
When is NAMS next annual earnings release?
The next annual earnings release for NAMS is on
Quarterly EBITDA
-$55.08M$19.49M-54.76%
Summary
- Current Value
- As of today, NAMS quarterly EBITDA is -$55.08M, down -54.76% on
- Historical Performance
- NAMS quarterly EBITDA is down -126.33% year-over-year, and down -2301.42% over the past 3 years
- All-Time High Comparison
- NAMS quarterly EBITDA is currently -43031.56% below its historical high of -$127.70K set on
- 3-Year Low Comparison
- NAMS quarterly EBITDA is +20.03% above its 3-year low of -$68.87M reached on
- Sector Comparison
- NAMS quarterly EBITDA is higher than 6.68% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly EBITDA | -$55.08M | -54.8% | -126.3% | -2301.4% | -10000.0% | |
| Annual EBITDA | -$241.49M | – | -36.5% | -483.7% | -3533.2% | |
| TTM EBITDA | -$202.72M | -17.9% | -54.2% | -3887.7% | -10000.0% | |
| Price | $35.80 | +8.9% | +40.1% | +202.3% | – | |
| PE Ratio | - | – | – | – | – | |
| Quarterly Revenue | $348.00K | -98.2% | -98.8% | +100.0% | +100.0% | |
| Quarterly EPS | -$0.61 | -313.0% | -244.4% | -124.7% | -10000.0% | |
| Quarterly EBIT | -$55.14M | -54.7% | -126.3% | -2304.2% | -10000.0% | |
| Quarterly Net Income | -$72.01M | -314.7% | -332.5% | -1406.3% | -10000.0% |
Quarterly EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | -$35.59M | -54.8% | |
| 3Y | -$2.29M | N/A | -2301.4% |
| 5Y | -$127.70K | N/A | >-9999.0% |
| All | -$127.70K | >-9999.0% |
Quarterly EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | -$68.87M | +20.0% | |
| 3Y | -$68.87M | +20.0% | |
| 5Y | -$68.87M | +20.0% | |
| All | -$68.87M | +20.0% |
Quarterly EBITDA History
FAQ
What is the current quarterly EBITDA of NAMS?
As of today, NAMS quarterly EBITDA is -$55.08M
What is NAMS quarterly EBITDA most recent change?
NAMS quarterly EBITDA was down -54.76% on September 30, 2025
What is 1-year change in NAMS quarterly EBITDA?
NAMS quarterly EBITDA is down -126.33% year-over-year
How far is NAMS quarterly EBITDA from its all-time high?
NAMS quarterly EBITDA is currently -43031.56% below its historical high of -$127.70K set on December 1, 2020
How does NAMS quarterly EBITDA rank versus sector peers?
NAMS quarterly EBITDA is higher than 6.68% of companies in Healthcare sector
When is NAMS next earnings release?
The next earnings release for NAMS is on
TTM EBITDA
-$202.72M$30.74M-17.88%
Summary
- Current Value
- As of today, NAMS TTM EBITDA is -$202.72M, down -17.88% on
- Historical Performance
- NAMS TTM EBITDA is down -54.20% year-over-year, and down -3887.73% over the past 3 years
- All-Time High Comparison
- NAMS TTM EBITDA is currently -158647.06% below its historical high of -$127.70K set on
- 3-Year Low Comparison
- NAMS TTM EBITDA is at its 3-year low
- Sector Comparison
- NAMS TTM EBITDA is higher than 7.23% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM EBITDA | -$202.72M | -17.9% | -54.2% | -3887.7% | -10000.0% | |
| Annual EBITDA | -$241.49M | – | -36.5% | -483.7% | -3533.2% | |
| Quarterly EBITDA | -$55.08M | -54.8% | -126.3% | -2301.4% | -10000.0% | |
| Price | $35.80 | +8.9% | +40.1% | +202.3% | – | |
| PE Ratio | - | – | – | – | – | |
| TTM Revenue | $35.24M | -44.9% | +7.5% | +100.0% | +100.0% | |
| TTM EPS | -$2.04 | -26.6% | -23.9% | -896.1% | -10000.0% | |
| TTM EBIT | -$202.93M | -17.9% | -54.3% | -3891.9% | -10000.0% | |
| TTM Net Income | -$221.07M | -33.4% | -48.0% | -5975.3% | -10000.0% |
TTM EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | -$171.98M | -17.9% | |
| 3Y | -$5.08M | N/A | -3887.7% |
| 5Y | -$127.70K | N/A | >-9999.0% |
| All | -$127.70K | >-9999.0% |
TTM EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | -$202.72M | at low | |
| 3Y | -$202.72M | at low | |
| 5Y | -$202.72M | at low | |
| All | -$202.72M | at low |
TTM EBITDA History
FAQ
What is the current TTM EBITDA of NAMS?
As of today, NAMS TTM EBITDA is -$202.72M
What is NAMS TTM EBITDA most recent change?
NAMS TTM EBITDA was down -17.88% on September 30, 2025
What is 1-year change in NAMS TTM EBITDA?
NAMS TTM EBITDA is down -54.20% year-over-year
How far is NAMS TTM EBITDA from its all-time high?
NAMS TTM EBITDA is currently -158647.06% below its historical high of -$127.70K set on December 1, 2020
How does NAMS TTM EBITDA rank versus sector peers?
NAMS TTM EBITDA is higher than 7.23% of companies in Healthcare sector
When is NAMS next earnings release?
The next earnings release for NAMS is on
EBITDA Formula
EBITDA = + + +
Data Sources & References
- NAMS Official Website www.newamsterdampharma.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1936258/000119312525265796/0001193125-25-265796-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1936258/000095017025027339/0000950170-25-027339-index.htm
- NAMS Profile on Yahoo Finance finance.yahoo.com/quote/NAMS
- NAMS Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/nams